Abvc Biopharma Stock Short Ratio
| ABVC Stock | USD 1.04 0.05 5.05% |
ABVC Biopharma fundamentals help investors to digest information that contributes to ABVC Biopharma's financial success or failures. It also enables traders to predict the movement of ABVC Stock. The fundamental analysis module provides a way to measure ABVC Biopharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ABVC Biopharma stock.
ABVC | Short Ratio |
ABVC Biopharma Company Short Ratio Analysis
ABVC Biopharma's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current ABVC Biopharma Short Ratio | 0.92 X |
Most of ABVC Biopharma's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABVC Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
ABVC Short Ratio Driver Correlations
Understanding the fundamental principles of building solid financial models for ABVC Biopharma is extremely important. It helps to project a fair market value of ABVC Stock properly, considering its historical fundamentals such as Short Ratio. Since ABVC Biopharma's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of ABVC Biopharma's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of ABVC Biopharma's interrelated accounts and indicators.
Click cells to compare fundamentals
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
| Competition |
Based on the latest financial disclosure, ABVC Biopharma has a Short Ratio of 0.92 times. This is 76.41% lower than that of the Biotechnology sector and 87.58% lower than that of the Health Care industry. The short ratio for all United States stocks is 77.0% higher than that of the company.
ABVC Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABVC Biopharma's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ABVC Biopharma could also be used in its relative valuation, which is a method of valuing ABVC Biopharma by comparing valuation metrics of similar companies.ABVC Biopharma is currently under evaluation in short ratio category among related companies.
ABVC Biopharma Institutional Holders
Institutional Holdings refers to the ownership stake in ABVC Biopharma that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ABVC Biopharma's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ABVC Biopharma's value.| Shares | Virtu Financial Llc | 2023-12-31 | 0.0 | Blackrock Inc | 2023-09-30 | 0.0 | Renaissance Technologies Corp | 2023-12-31 | 36.1 K | Vanguard Group Inc | 2023-12-31 | 27.2 K | Geode Capital Management, Llc | 2023-12-31 | 19.5 K | Citadel Advisors Llc | 2023-09-30 | 15.6 K | Tower Research Capital Llc | 2023-12-31 | 578 | Spotlight Asset Group, Inc. | 2023-12-31 | 100.0 | Royal Bank Of Canada | 2023-12-31 | 37.0 | Wells Fargo & Co | 2023-12-31 | 20.0 | Northern Trust Corp | 2023-09-30 | 0.0 |
ABVC Fundamentals
| Return On Equity | -1.92 | ||||
| Return On Asset | -0.43 | ||||
| Operating Margin | (906.06) % | ||||
| Current Valuation | 12.48 M | ||||
| Shares Outstanding | 10.56 M | ||||
| Shares Owned By Insiders | 26.97 % | ||||
| Shares Owned By Institutions | 2.43 % | ||||
| Number Of Shares Shorted | 1.32 M | ||||
| Price To Book | 1.36 X | ||||
| Price To Sales | 75.52 X | ||||
| Revenue | 152.43 K | ||||
| Gross Profit | 350.71 K | ||||
| EBITDA | (8.19 M) | ||||
| Net Income | (10.52 M) | ||||
| Cash And Equivalents | 2.99 M | ||||
| Cash Per Share | 0.09 X | ||||
| Total Debt | 2.45 M | ||||
| Debt To Equity | 0.34 % | ||||
| Current Ratio | 2.68 X | ||||
| Book Value Per Share | 1.06 X | ||||
| Cash Flow From Operations | (4.06 M) | ||||
| Short Ratio | 0.92 X | ||||
| Earnings Per Share | (2.43) X | ||||
| Target Price | 2.02 | ||||
| Number Of Employees | 16 | ||||
| Beta | 0.77 | ||||
| Market Capitalization | 10.46 M | ||||
| Total Asset | 14.94 M | ||||
| Retained Earnings | (65.42 M) | ||||
| Working Capital | (4.28 M) | ||||
| Net Asset | 14.94 M |
About ABVC Biopharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ABVC Biopharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABVC Biopharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABVC Biopharma based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ABVC Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ABVC Biopharma's short interest history, or implied volatility extrapolated from ABVC Biopharma options trading.
Pair Trading with ABVC Biopharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ABVC Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ABVC Biopharma will appreciate offsetting losses from the drop in the long position's value.Moving against ABVC Stock
| 0.64 | PAHC | Phibro Animal Health Financial Report 1st of May 2024 | PairCorr |
| 0.64 | CNTA | Centessa Pharmaceuticals Downward Rally | PairCorr |
| 0.59 | ANIP | ANI Pharmaceuticals Financial Report 13th of May 2024 | PairCorr |
| 0.51 | ELYM | Eliem Therapeutics | PairCorr |
| 0.51 | PBH | Prestige Brand Holdings Financial Report 2nd of May 2024 | PairCorr |
The ability to find closely correlated positions to ABVC Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ABVC Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ABVC Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ABVC Biopharma to buy it.
The correlation of ABVC Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ABVC Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ABVC Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ABVC Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out ABVC Biopharma Piotroski F Score and ABVC Biopharma Altman Z Score analysis. For information on how to trade ABVC Stock refer to our How to Trade ABVC Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Complementary Tools for ABVC Stock analysis
When running ABVC Biopharma's price analysis, check to measure ABVC Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ABVC Biopharma is operating at the current time. Most of ABVC Biopharma's value examination focuses on studying past and present price action to predict the probability of ABVC Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ABVC Biopharma's price. Additionally, you may evaluate how the addition of ABVC Biopharma to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is ABVC Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ABVC Biopharma. If investors know ABVC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ABVC Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.43) | Revenue Per Share 0.035 | Quarterly Revenue Growth (1.00) | Return On Assets (0.43) | Return On Equity (1.92) |
The market value of ABVC Biopharma is measured differently than its book value, which is the value of ABVC that is recorded on the company's balance sheet. Investors also form their own opinion of ABVC Biopharma's value that differs from its market value or its book value, called intrinsic value, which is ABVC Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ABVC Biopharma's market value can be influenced by many factors that don't directly affect ABVC Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ABVC Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ABVC Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ABVC Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.